847 results on '"Poirier, Judes"'
Search Results
2. Neuromodulatory subcortical nucleus integrity is associated with white matter microstructure, tauopathy and APOE status
3. The neurophysiological brain-fingerprint of Parkinson’s disease
4. How Do Modifiable Risk Factors Affect Alzheimer’s Disease Pathology or Mitigate Its Effect on Clinical Symptom Expression?
5. Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease
6. The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study
7. CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem
8. Altered declarative memory in introverted middle-aged adults carrying the BDNF val66met allele
9. Association between BDNF polymorphism and hypothalamic-pituitary-adrenal activity in later adulthood
10. Association of TMEM106B with Cortical APOE Gene Expression in Neurodegenerative Conditions
11. APOEε4 potentiates the relationship between amyloid-β and tau pathologies
12. Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease: Vascular risk factors and functional connectivity changes
13. Reduced rapid eye movement sleep in late middle-aged and older apolipoprotein E ɛ4 allele carriers.
14. Longer sleep duration and neuroinflammation in at-risk elderly with a parental history of Alzheimer's disease.
15. Locus coeruleus integrity is related to an exploitation-based decision-making bias in older adulthood.
16. Iron Deposition and Distribution Across the Hippocampus Is Associated with Pattern Separation and Pattern Completion in Older Adults at Risk for Alzheimer’s Disease.
17. Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains.
18. The role of biofluid markers in predicting near‐term cognitive impairment
19. Dissociable influences of maternal vs paternal Alzheimer’s risk on neurocognitive and cardiovascular health in men and women
20. Evaluation of HIVEP3 polymorphic variants and gene expression in Alzheimer’s disease
21. Sex and family history differences in Aβ and tau vulnerability in preclinical Alzheimer’s disease
22. Study of TMEM106B expression levels under neurodegenerative conditions
23. Sleep Quality and Day‐to‐Day Variability: Relation to Alzheimer’s pathology in Cognitively Unimpaired Older Adults At‐Risk of AD Dementia
24. Unique CSF lipid signature in asymptomatic subjects with a parental history of Alzheimer’s disease and its association with key apolipoprotein species
25. Association of PPP2R1A with Alzheimer's disease and specific cognitive domains
26. Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology
27. Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation
28. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
29. Chapter 7 - Pharmacogenomic approaches to the treatment of sporadic Alzheimer’s disease
30. Biomarkers of dementia in obstructive sleep apnea
31. Contactin 5 and Apolipoproteins Interplay in Alzheimer's Disease.
32. List of contributors
33. Pharmacogenomic approaches to the treatment of sporadic Alzheimer’s disease
34. CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease
35. Isoprenoids and tau pathology in sporadic Alzheimer's disease
36. Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer’s Disease
37. Association of education with Aβ burden in preclinicial familial and sporadic Alzheimer disease
38. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium.
39. Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly.
40. Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease.
41. Assessment of white matter hyperintensity severity using multimodal magnetic resonance imaging.
42. INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
43. Social isolation is linked to classical risk factors of Alzheimer’s disease-related dementias
44. Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease
45. Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression
46. Dynamic Amyloid and Metabolic Signatures of Delayed Recall Performance within the Clinical Spectrum of Alzheimer’s Disease
47. Characterization of the contactin 5 protein and its risk‐associated polymorphic variant throughout the Alzheimer's disease spectrum
48. APOE alleles are associated with sex-specific structural differences in brain regions affected in Alzheimer’s disease and related dementia
49. LDLR, VLDLR and APOBR in the pathophysiology of sporadic Alzheimer’s disease
50. Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.